Nordic Nanovector Feed

Land	Norge
Lista	OB Match
Sektor	Hälsovård
Industri	Läkemedel & Handel

2021-10-19 07:00:16 NANOV: Nordic Nanovector enters research collaboration with the University of Pennsylvania to generate a novel CD37-targeting CAR-T cell approach +5,71% | 22,9 MNOK

2021-10-19 07:00:00 Nordic Nanovector enters research collaboration with the University of Pennsylvania to generate a novel CD37-targeting CAR-T cell approach +5,71% | 22,9 MNOK

2021-09-20 10:25:19 Nordic Nanovector ASA - allocation of PSUs -5,59% | 13,2 MNOK

2021-09-20 10:25:13 Nordic Nanovector ASA - allocation of PSUs -5,59% | 13,2 MNOK

2021-09-14 18:08:38 NANOV: Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer +4,82% | 8,74 MNOK

2021-09-14 18:08:24 Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer +4,82% | 8,74 MNOK

2021-08-27 07:01:13 Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021 +11,67% | 49,4 MNOK

2021-08-27 07:01:00 Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021 +11,67% | 49,4 MNOK

2021-08-27 07:00:14 Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 2021 +11,67% | 49,4 MNOK

2021-08-27 07:00:00 Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 2021 +11,67% | 49,4 MNOK

2021-08-20 08:00:17 Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2021 Results Presentation Webcast -3,16% | 6,92 MNOK

2021-08-20 08:00:00 Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2021 Results Presentation Webcast -3,16% | 6,92 MNOK

2021-08-03 23:11:16 NANOV: Nordic Nanovector Provides Update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma -13,52% | 26,8 MNOK

2021-08-03 23:11:01 Nordic Nanovector Provides Update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma -13,52% | 26,8 MNOK

2021-07-01 07:30:06 NANOV: Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer -12,06% | 67,4 MNOK

2021-07-01 07:30:00 Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer -12,06% | 67,4 MNOK

2021-06-22 18:19:39 Nordic Nanovector ASA: Share capital increase registered +3,83% | 16,1 MNOK

2021-06-22 18:19:31 Nordic Nanovector ASA: Share capital increase registered +3,83% | 16,1 MNOK

2021-06-22 07:00:08 NANOV: Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) -1,84% | 32,4 MNOK

2021-06-22 07:00:00 Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) -1,84% | 32,4 MNOK

2021-06-18 17:00:06 Nordic Nanovector ASA: Increase of share capital -0,38% | 8,94 MNOK

2021-06-18 17:00:00 Nordic Nanovector ASA: Increase of share capital -0,38% | 8,94 MNOK

2021-06-18 16:59:06 Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors -0,38% | 8,94 MNOK

2021-06-18 16:59:00 Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors -0,38% | 8,94 MNOK

2021-06-18 08:00:22 Nordic Nanovector ASA: Increase of share capital +1,39% | 11,6 MNOK

2021-06-18 08:00:11 Nordic Nanovector ASA: Increase of share capital +1,39% | 11,6 MNOK

2021-06-02 07:00:17 Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors +2,07% | 13,8 MNOK

2021-06-02 07:00:00 Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors +2,07% | 13,8 MNOK

2021-05-26 07:01:06 Nordic Nanovector ASA: Results for the First Quarter 2021 -16,49% | 105 MNOK

2021-05-26 07:01:00 Nordic Nanovector ASA: Results for the First Quarter 2021 -16,49% | 105 MNOK

2021-05-26 07:00:06 Nordic Nanovector ASA: Resultat for første kvartal 2021 -16,49% | 105 MNOK

2021-05-26 07:00:00 Nordic Nanovector ASA: Resultat for første kvartal 2021 -16,49% | 105 MNOK

2021-05-25 07:00:07 NANOV: Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma +9,60% | 85,2 MNOK

2021-05-25 07:00:00 Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma +9,60% | 85,2 MNOK

2021-05-20 08:00:00 Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast +1,79% | 11,1 MNOK

2021-04-28 15:13:16 Nordic Nanovector ASA: Annual General Meeting held -1,07% | 19,6 MNOK

2021-04-28 15:13:04 Nordic Nanovector ASA: Annual General Meeting held -1,07% | 19,6 MNOK

2021-04-20 10:37:36 Nordic Nanovector ASA - Share capital increase registered -2,81% | 12,3 MNOK

2021-04-20 10:37:17 Nordic Nanovector ASA - Share capital increase registered -2,81% | 12,3 MNOK

2021-04-12 07:30:02 Nordic Nanovector ASA - Final results of the repair offering -4,33% | 16,4 MNOK

2021-04-12 07:30:00 Nordic Nanovector ASA - Final results of the repair offering -4,33% | 16,4 MNOK

2021-04-09 17:54:28 Nordic Nanovector ASA - Preliminary results of the repair offering -4,33% | 16,4 MNOK

2021-04-09 17:54:24 Nordic Nanovector ASA - Preliminary results of the repair offering -4,33% | 16,4 MNOK

2021-04-07 13:00:17 Nordic Nanovector ASA: Notice of Annual General Meeting on 28 April 2021 -1,39% | 8,17 MNOK

2021-04-07 13:00:00 Nordic Nanovector ASA: Notice of Annual General Meeting on 28 April 2021 -1,39% | 8,17 MNOK

2021-04-07 12:59:15 NANOV: Nordic Nanovector ASA Announces Proposed Board Change -1,39% | 8,17 MNOK

2021-04-07 12:59:00 Nordic Nanovector ASA Announces Proposed Board Change -1,39% | 8,17 MNOK

2021-03-26 23:05:09 NANOV: Nordic Nanovector ASA publishes 2020 Annual Report +5,81% | 33,3 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2021-11-18	Kvartalsrapport 2021-Q3
2021-08-27	Kvartalsrapport 2021-Q2
2021-08-26	Kvartalsrapport 2021-Q2
2021-05-26	Kvartalsrapport 2021-Q1
2021-04-28	Årsstämma 2021
2021-04-16	Ordinarie utdelning NANOV 0.00 NOK
2021-03-22	Extra Bolagsstämma 2021
2021-02-18	Bokslutskommuniké 2020
2020-11-19	Kvartalsrapport 2020-Q3
2020-10-21	Extra Bolagsstämma 2020
2020-08-27	Kvartalsrapport 2020-Q2
2020-06-11	Ordinarie utdelning NANOV 0.00 NOK
2020-06-10	Årsstämma 2020
2020-05-26	Kvartalsrapport 2020-Q1
2020-02-27	Bokslutskommuniké 2019
2019-11-19	Kvartalsrapport 2019-Q3
2019-08-22	Kvartalsrapport 2019-Q2
2019-05-23	Kvartalsrapport 2019-Q1
2019-04-26	Ordinarie utdelning NANOV 0.00 NOK
2019-04-25	Årsstämma 2019
2019-02-18	Extra Bolagsstämma 2019
2018-08-22	Kvartalsrapport 2018-Q2
2018-05-31	Ordinarie utdelning NANOV 0.00 NOK
2018-05-30	Årsstämma 2018
2018-05-30	Kvartalsrapport 2018-Q1
2018-02-27	Bokslutskommuniké 2017
2017-12-20	Extra Bolagsstämma 2017
2017-11-22	Kvartalsrapport 2017-Q3
2017-08-23	Kvartalsrapport 2017-Q2
2017-05-26	Ordinarie utdelning NANOV 0.00 NOK
2017-05-24	Kvartalsrapport 2017-Q1
2017-05-24	Årsstämma 2017
2017-02-28	Bokslutskommuniké 2016
2016-11-23	Kvartalsrapport 2016-Q3
2016-10-12	Extra Bolagsstämma 2016
2016-08-24	Kvartalsrapport 2016-Q2
2016-05-31	Kapitalmarknadsdag 2016
2016-05-20	Ordinarie utdelning NANOV 0.00 NOK
2016-05-19	Kvartalsrapport 2016-Q1
2016-05-19	Årsstämma 2016
2016-02-26	Bokslutskommuniké 2015
2015-11-17	Kapitalmarknadsdag 2015
2015-10-21	Kvartalsrapport 2015-Q3
2015-08-26	Kvartalsrapport 2015-Q2
2015-05-27	Kvartalsrapport 2015-Q1
2015-03-09	Årsstämma 2015
2014-11-12	Extra Bolagsstämma 2014

Nordic Nanovector

Beskrivning

Kalender

Nordic Nanovector

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Ett Mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden